NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis $1.95 -0.03 (-1.52%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.94 -0.01 (-0.77%) As of 08/1/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cronos Group Stock (NASDAQ:CRON) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cronos Group alerts:Sign Up Key Stats Today's Range$1.93▼$2.0150-Day Range$1.86▼$2.1452-Week Range$1.60▼$2.46Volume2.31 million shsAverage Volume1.28 million shsMarket Capitalization$752.08 millionP/E Ratio15.00Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. Read More Cronos Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks46th Percentile Overall ScoreCRON MarketRank™: Cronos Group scored higher than 46% of companies evaluated by MarketBeat, and ranked 572nd out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cronos Group. Earnings and Valuation2.5 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.03) to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is 15.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is 15.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.67.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cronos Group's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.27% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cronos Group has recently decreased by 11.23%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.27% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cronos Group has recently decreased by 11.23%, indicating that investor sentiment is improving significantly. News and Social Media2.3 / 5News Sentiment0.14 News SentimentCronos Group has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cronos Group this week, compared to 2 articles on an average week.Search Interest6 people have searched for CRON on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.30% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 8.71% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CRON Stock News HeadlinesCronos: The New Dawn’s Leads Reveal Its Origins, The Horrors That Inspired It, And The Lessons Learned From Silent Hill 2July 29, 2025 | msn.comCronos Group (CRON) Expands its Reach to Europe with a New PartnershipJuly 28, 2025 | msn.comThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it. | Crypto 101 Media (Ad)Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025July 25, 2025 | globenewswire.comCronos Group (NASDAQ:CRON) vs. CERo Therapeutics (NASDAQ:CERO) Financial AnalysisJuly 25, 2025 | americanbankingnews.comHigh Tide Closes on $30 Million Convertible Debt from Cronos Group Inc.July 16, 2025 | prnewswire.comCryptocurrencies Price Prediction: Zcash, Bitcoin & Cronos — Asian Wrap 9 JulyJuly 9, 2025 | fxstreet.comCronos Grows its International Footprint in SwitzerlandJuly 2, 2025 | globenewswire.comSee More Headlines CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at $2.02 on January 1st, 2025. Since then, CRON stock has decreased by 3.5% and is now trading at $1.95. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) released its quarterly earnings data on Thursday, May, 8th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.01. The business earned $33.62 million during the quarter, compared to analysts' expectations of $45.44 million. Cronos Group had a net margin of 39.69% and a negative trailing twelve-month return on equity of 0.07%. Read the conference call transcript. Who are Cronos Group's major shareholders? Top institutional investors of Cronos Group include Public Employees Retirement System of Ohio (0.02%), Mraz Amerine & Associates Inc. (0.01%), Envestnet Asset Management Inc. and International Assets Investment Management LLC. View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings5/08/2025Today8/01/2025Next Earnings (Estimated)8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CRON CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees450Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.13 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$41.08 million Net Margins39.69% Pretax Margin37.64% Return on Equity-0.07% Return on Assets-0.07% Debt Debt-to-Equity RatioN/A Current Ratio27.80 Quick Ratio26.75 Sales & Book Value Annual Sales$117.61 million Price / Sales6.39 Cash Flow$0.00 per share Price / Cash Flow4,255.14 Book Value$2.90 per share Price / Book0.67Miscellaneous Outstanding Shares385,680,000Free Float357,527,000Market Cap$752.08 million OptionableOptionable Beta1.01 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:CRON) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.